Skip to content

Perioperative FLOW-controlled VENTilation (FCV) versus pressure-controlled ventilation (PCV) IN on-pump HEART SURGery: A prospective randomized-controlled clinical trial

Perioperative FLOW-controlled VENTilation (FCV) versus pressure-controlled ventilation (PCV) IN on-pump HEART SURGery: A prospective randomized-controlled clinical trial - FLOWVENTIN HEARTSURG

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00018956
Enrollment
140
Registered
2020-06-12
Start date
2020-08-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing an elective cardiac surgery procedure with intraoperative utilization of the heart-lung-maschine and perioperative ventilation.

Interventions

Group 1: Perioperative pressure-controlled ventilation (PCV-group) Group 2: Perioperative flow-controlled ventilation (FCV-Group, Evone®, Ventinova Medical)

Sponsors

Klinik für Anästhesiologie, Intensiv- und Schmerzmedizin Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil gGmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Participants scheduled for an elective cardiac surgery procedure with intraoperative utilization of the heart-lung-machine and aortic cross-clamping excluding heart transplantation and any ventricular assist device implantation. Participants need to have given written informed consent into study participation on the day before the surgery.

Exclusion criteria

Exclusion criteria: Exclusion criteria: - the patient is not independently able to consent into study participation - participation in another perioperative clinical intervention study - patients with suspected or confirmed endocarditis and/or pneumonia before surgery - preoperative immunosuppresive medication. Stop criteria: - more than one cardiopulmonary bypass time due to major intraoperative complications - intraoperative death and/or cardiopulmonary resuscitation which are exclusively due to major intraoperative surgical complications - protocol deviations > 5 minutes with respect to the intervention of ventilation

Design outcomes

Primary

MeasureTime frame
Plasma concentration of interleukin 8 (IL-8) six hours after cardiopulmonary bypass (Enzyme-Linked Immunosorbent Assay, ELISA).

Secondary

MeasureTime frame
Main study: - perioperative oxygenation indices - venilation pressures - incidence of postoperative pneumonias - incidence of postoperative pulmonary complications during the first seven postoperative days - SIRS-free days during the first seven postoperative days - weaning durations - length of intensive / intermediate care unit, normal ward and total intrahospital stays Sub studies: - perioperative evaluation of parameters regarding right ventricular function in transthoracic and transoesophageal echocardiography (for example: Right ventricular Index of Myocardial Performance (RIMP) - perioperative parameters of Electrical Impedance Tomography (EIT) (for example: dorsal gradient of ventilated area) - perioperative humoral and cellular inflammation and lung injury on different levels.

Countries

Germany

Contacts

Public ContactSimon Becker

Klinik für Anästhesiologie, Intensiv- und Schmerzmedizin, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil gGmbH

simon.becker@bergmannsheil.de+49 - 234 - 302 6917

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 11, 2026